Senexis
Unfolding the Science of Senescence to revolutionise the diagnosis & treatment of ageing-related diseases

You are here : Home

Welcome to Senexis - unfolding the science of senescence......................

Senexis is a growing, small-molecule drug development company that is committed to revolutionising the treatment and diagnosis of diseases resulting from the inevitable process of ageing. Senexis is advancing a pipeline of novel treatments for diseases resulting from the toxicity of amyloid-like proteins.

Our pipeline is currently focused on discovering potent and selective therapies for the treatment of the following ageing-related diseases:

CLICK HERE TO LINK TO BIOPARTNERING EUROPE 2008

Last updated 15th September, 2008